Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
AMOXICILLIN TRIHYDRATE CLAVULANATE POTASSIUM
PCO Manufacturing
500/125 Base Milligrams
Film Coated Tablet
2001-07-27
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Augmentin Duo 500 mg / 125 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains amoxicillin trihydrate equivalent to 500 mg amoxicillin and potassium clavulanate equivalent to 125 mg clavulanic acid. _For full list of excipients, see section 6.1._ 3 PHARMACEUTICAL FORM Film-coated tablet. Product imported from the UK: White, oval, tablets; engraved ‘AUGMENTIN’ on one side, plain on the other side. Product imported from Greece and Spain: White, oval, tablets with a breakline on one side, ‘A’ on one side of the line and ‘C’ on the other and plain on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Augmentin Duo, for twice daily(b.i.d.) dosing, is indicated for short term treatment of bacterial infections at the following sites when amoxycillin resistant beta-lactamase producing strains are suspected as the cause. In other situations, amoxycillin alone should be considered. ○ _Upper Respiratory Tract Infections (including ENT) _in particular sinusitis, otitis media, recurrent tonsillitis. These infections are often caused by _Streptococcus pneumoniae,_ _Haemophilus influenzae_ _*_ _, Moraxella catarrhalis_ _*_ and _Streptococcus pyogenes._ ○ _Lower Respiratory Tract Infections _in particular acute exacerbations of chronic bronchitis (especially if considered severe), bronchopneumonia. These infections are often caused by _Streptococcus pneumoniae, Haemophilus_ _influenzae_ _*_ and _Moraxella catarrhalis_ _*_ _._ ○ _Genito-urinary Tract and Abdominal Infections _in particular cystitis (especially when recurrent or complicated – excluding prostatis), septic abortion, pelvic or puerperal sepsis and intra-abdominal sepsis. These infections are often caused by _Ente Read the complete document